These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6050666)

  • 1. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 5. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chelates in the treatment of obliterating arterial diseases. (Preliminary report)].
    Brücknerová O; Tulácek J; Krojzl O
    Vnitr Lek; 1968 Sep; 14(9):841-5. PubMed ID: 4971419
    [No Abstract]   [Full Text] [Related]  

  • 7. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intra-arterial treatment of arterial obliterative disease (author's transl)].
    Mörl H
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2284-6. PubMed ID: 4448136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 13. [PROLONGED INTRA-ARTERIAL INFUSIONS WITH VASODILATORS AND LOW-MOLECULAR WEIGHT DEXTRAN IN THE TREATMENT OF PERIPHERAL ARTERIAL CIRCULATION DISORDERS].
    MARTI WK
    Schweiz Med Wochenschr; 1963 Dec; 93():1746-9. PubMed ID: 14098621
    [No Abstract]   [Full Text] [Related]  

  • 14. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 15. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 19. [OUR EXPERIENCE WITH INTERAARTERIAL THERAPEUTICS IN ARTERIOPATHIES OF THE LOWER EXTREMITIES].
    KITAINIK E; CUNEO JL; SWIATLO MR; BREYTER E; QUINTANA C
    Sem Med; 1964 Jan; 124():333-6. PubMed ID: 14129176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A; Bory M; Poggi L; Audier M
    Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.